This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Effectiveness results
Of the 31 patients in the EP-guided group, 10 had sole antiarrhythmic therapy, 5 had VT surgery after the failure of the initial antiarrhythmic therapy, and 16 had late ICD after the failure of the initial antiarrhythmic therapy and VT surgery (in one case). The early ICD group had 4 deaths versus 11 in the EP-guided group; (hazard ratio: 0.34);(95% CI: 0.11 -1.08); (p=0.07). Seven patients died in the subgroup of patients who had sole antiarrhythmic therapy. In terms of secondary outcome measures, only the EP-guided group experienced recurrent cardiac arrest; and the early ICD group had significantly better outcomes with respect to exercise tolerance, duration of hospitalisation, number of invasive procedures, and changes of antiarrhythmic therapy. One case of cardiac transplantation occurred in the EP-guided group.
Clinical conclusions
The study results confirm that ICD is superior to drug therapy in terms of clinical effectiveness.
Measure of benefits used in the economic analysis
The benefit measure was total days alive for each study group.
Direct costs
Costs were not discounted ""because the median follow-up was only 2 years". Quantities were not reported separately from the costs. Cost items were reported separately. Cost analysis covered the costs of hospitalisation; visits to outpatient clinics; all diagnostic investigations; and all therapeutic procedures, including drug treatment and domiciliary care. The perspective adopted in the cost analysis was that of Dutch private health insurance. Charges were used as opposed to real costs and were based on the lowest class scale rates of the Dutch private health insurance used by the billing department of the University Hospital Utrecht. The source of cost data was one of the study institutions. Cost results were estimated for the years 1990, 1992 and 1993.
Indirect Costs
Not considered.
Currency

US dollars ($).
Sensitivity analysis
A series of one-way sensitivity analyses was performed on hospitalisation charges (based on three different levels of hospital charges in 1990, 1992, and 1993) , sudden death rate (lower rate), therapy efficacy assessment without EP testing, and exclusion of VT surgery as a therapeutic option.
